Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Explore presentations by leading experts from iwAL 2023 below. Click here to view the roundtable discussion for each of the sessions.
Session 1: New research perspectives in AML
Session 2: Controversies in AML
Session 3: New frontiers in MRD for AML clinical practice
Session 4: BPDCN & MDS/MPN + CMML
Session 5: Novel targets, combinations and treatments in AML
Part 1 – new AML therapies and limitations
Session 6: Special session on regulatory endpoints in AML
Session 7: Novel targets, combinations, and treatments in AML
Part 2 – what do we know about drug resistance?
Session 8: Transplant and immunotherapies in AML
The continued success of the iwAL meeting is in no small part due to the ongoing funding of supporters, allowing a unique opportunity for clinicians to be brought together to facilitate interactive and stimulating debates to help improve patient outcomes.
For more information about supporting future meetings and activities, please contact us here.
iwAL 2023 has been supported by: